Cot-ticotropin-releasing factor (CRF) receptor-binding sites have been localized and quantified in the rat central nervous system (CNS) by autoradiography with an iodine-125labeled analogue of ovine CRF substituted with norleucine and tyrosine at amino acid residues 21 and 32, respectively. High affinity and pharmacologically specific receptor-binding sites for CRF were found in discrete areas within the rat CNS. CRF receptors were highly concentrated in laminae 1 and 4 throughout the neocortex, the external plexiform layer of the olfactory bulb, the external layer of the median eminence, several cranial nerve nuclei in the brainstem including the facial, oculomotor, trochlear, vestibulocochlear, and trigeminal nuclei, the deep cerebellar nuclei, and the cerebellar cortex. Moderate concentrations of CRF receptors were present in the olfactory tubercle, caudate-putamen, claustrum, nucleus accumbens, nucleus of the diagonal band, basolateral nucleus of the amygdala, paraventricular nucleus of the hypothalamus, mammillary peduncle, inferior and superior olives, medullary reticular formation, inferior colliculus, and brainstem nuclei including tegmental, parabrachial, hypoglossal, pontine, cuneate, and gracilis nuclei, and in spinal cord. Lower densities of CRF binding were found in the bed nucleus of the stria terminalis, central and medial amygdaloid nuclei, and regions of the thalamus, hypothalamus, hippocampus, and brainstem. The distribution of CRF-binding sites generally correlates with the immunocytochemical distribu-
Abuse, P.O. Box 5180, Baltimore, MD 21224. tion of CRF pathways and with the pharmacological sites of action of CRF. These data strongly support a physiological role for endogenous CRF in regulating and integrating functions in the CNS.
The primary role of a hypothalamic factor in regulating pituitaryadrenocortical secretion has been well established (Harris, 1948; Yasuda et al., 1982) . In 1981, Vale and colleagues reported the isolation, characterization, sequence, synthesis, and biologic activity of a 41 -amino acid hypothalamic ovine corticotropin-releasing factor (CRF) that fulfills many of the criteria of a physiological regulator of adrenocorticotropin (ACTH) secretion (Spiess et al., 1981; Vale et al., 1981) . Synthetic CRF is a potent stimulus for the release of ACTH (Vale et al., 1981 (Vale et al., , 1983 Turkelson et al., 1981; Gibbs et al., 1982; Grossman et al., 1982; Hook et al., 1982; C. Rivier et al., 1982 C. Rivier et al., , 1983 Nussbaum et al., 1983; Orth et al., 1983; Gold et al., 1984 ) P-endorphin (Gibbs et al., 1982; C. Rivier et al., 1982; Nussbaum et al., 1983; Vale et al., 1983) and other pro-opiomelanocortin-derived peptides (Al-Noaemi et al., 1982; Meunier et al., 1982; Proulx-Ferland et al., 1982) from the pituitary gland in a variety of species including rats, sheep, monkeys, and humans. In addition to its endocrine activity in the pituitary gland, CRF has a wide variety of extrahypophysiotropic effects, lntracerebroventricular administration of CRF elicits autonomic (Brown et al., 1982a, b; Fisher et al., 1982 Fisher et al., , 1983 Kalin et al., 1983; Tache et al., 1983; lnsel et al., 1984) electrophysiological (Aldenhoff et al., 1983; Eberly et al., 1983; Ehlers et al., 1983; Valentino et al., 1983) and behavioral (D. R. Britton et al., 1982 Britton et al., , 1984 Morley and Levine, 1982; Sutton et al., 1982; Levine et al., 1983; Sahgal et al., 1983; Sirinathsinghji et al., 1983; Koob et al., 1984; Veldhuis and DeWeid, 1984) effects, suggesting that it may play a role in the organism's response to stress. Radioimmunoassay (Fischman and Moldow, 1982; Cote et al., 1983; Hashimoto et al., 1983; Palkovits et al., 1983) and immunocytochemical (Bloom et al., 1982; Bugnon et al., 1982; Olschowka et al., 1982; Cummings et al., 1983; Lerenth et al., 1983; Merchenthaler et al., 1983; Paul1 and Gibbs, 1983; Swanson et al., 1983) studies have demonstrated that CRF-like immunoreactivity is distributed throughout the rat central nervous system (CNS). These pharmacological and immunohistochemical data suggest that CRF may function as a neurotransmitter or neuromodulator in the CNS.
Earlier we identified and characterized high affinity receptors for CRF in rat (De Souza et al., 1984a) and human (De Souza et al., 1985) anterior pituitary glands and in rat intermediate pituitary (De Souza et al., 1984a) . More recently, we reported the autoradiographic identification of CRF receptors in selected regions of rat forebrain 3189 In DPM/mg protein Figure 7 . Relafionshrp between the relative optical density in Ultrofilm and the concentration of iodine-125 as derived from the Loats computerized Image analysis system for receptor autoradiograms.
Tissue blocks of bovine caudate (gray matter) and bovrne corpus callosum (white matter) were soaked in iodine-125.labeled compounds, and apposed to Ultrofilm. After exposure, the radioactivity and protein concentration in the standards were measured directly after scraping the tissue sections from the slides, The data are in "relative" optical density because the optical density measurements were not standardized in the image analysis. The regression line had a correlation coefficient of r 2 0.99 (p < 0.001). effects of incubation with brain tissue. Aliquots of Nle", in the medium, before (0) and 120 min after (0) incubation with brain tissue were analyzed by RP-HPLC using conditions described under "Materials and Methods."
The elution position of unlabeled Nle", Ty?*-oCRF (dashed line) was determined by absorbance at 220 nm.
using an iodine-125labeled ovine CRF analogue substituted with norleucine and tyrosine at amino acid residues 21 and 32, respectively (De Souza et al., 1984b) . In this report, we describe in greater detail the autoradiographic distribution of CRF receptors in the rat CNS. These autoradiographic studies have been undertaken to indicate the anatomical loci at which CRF may produce its CNS effects.
Materials and Methods lodmation
and purification of N/e", Ty?'-oCRF. Nle", Ty?*-oCRF was iodinated by reaction of 2 fig of peptide with 1 .O mCi of Na'? (Amersham Corp., Arlington Herght, IL) in the presence of one lodobead (Pierce Chemical Co., Rockford, IL). The reaction was allowed to proceed for 5 min at room temperature and was stopped by addition of 5 ~1 of 2-mercaptoethanol. The iodination mixture was diluted with 3.0 ml of solution A (20% acetonitrile in 0.1% trifluoroacetic acid) and cycled onto an ODS Sep-Pak cartridge (Waters Associates, Milford, MA) five times; the cartridge was then washed with 20 ml of solution A and eluted with SIX 0.5ml aliquots of solution B (80% acetonitrile in 0.1% trifluoroacetic acid). The two most radioactive fractions were pooled and dried under a stream of NZ; the contents were then dissolved in 200 ~1 of solution A. The iodine-125.labeled Nle2', Ty?*-oCRF (Nle", '251-Ty?*-oCRF) was purified by reversed phase high pressure liquid chromatography (RP-HPLC) on a Waters C18 (ODS) b-Bondapak column (4.6 mm x 30 cm) equilibrated with solution A at a flow rate of 1.0 ml/min; 10 min after sample injection, a lrnear gradient to 85% solution B over 65 min was Initiated. Unlabeled Nle", Ty?oCRF was detected by absorbance at 220 nm. Tissue preparation.
Male Sprague-Dawley (Madison, WI) rats weighing 200 to 300 gm were anesthetized with pentobarbital and perfused intracardially with 500 to 700 ml of a mtxture of equal parts of phosphate-buffered saltne and 0.32 M sucrose (pH 7.4). The brains and spinal cords were then rapidly removed, embedded in homogenized brain paste, and frozen in powdered dry ice. The tissues were sectioned (8 pm) using a microtome (Harris; N. Billerica, MA) at -16°C thaw-mounted onto chrome alum/gelatinsubbed microscope slides, and stored at -20°C until used. In biochemical studies involving characterization of the receptor, we used slide-mounted coronal sections of rat forebrain through the diencephalon (one 1 O-pm section per slide). Sections from at least 15 animals were subsequently used to generate autoradiograms.
Receptor labeling in slide-mounted brain sections. Slrde-mounted tissue sections were brought to room temperature and incubated with 0.1 to 0.2 nM Nle*' '"51-Ty?z-oCRF in 50 mM Tns-HCI (pH 7.4) containing 5 mM MgC12, 2 mM EdTA, 0.1% bovine serum albumin (BSA), aprotinrn (100 KIU/ml), and 0.1 mM bacitracin (Sigma Chemical Co., St. Louis, MO) at room temperature. Blanks were incubated in the same medium with the addition of 1 pM Nle", Nl~2','251-Tyr32-&RF -0 .25   0  5  10  15  20  25  30  35  40  45  50  55  e4  65  70  75  80 Retention Time I min I et al., 1981) or Kodak NTB-3 emulsron-coated glass (Young and Kuhar, 1979) or Aclar plastic coverslrps, (De Souza et al., 198413) and after 7 to 14 days of exposure at 4°C the autoradiograms were developed and the tissue was stained with toluidine blue. Following the staining procedures, the sections were dried, and the coverslips were reapposed and set with Permount.
Data analysis. In autoradiograms prepared with NTB-3 emulsion, grain counts were made by eye using a x 100 oil immersion objective on a Zeiss mrcroscope equipped wrth a grid-containing eyepiece.
In autoradrograms prepared with trrtrum-sensitive film, optical density readings, construction of standard curves, and rapid quantification were carried out using a Loats PCbased computerized image analysis system (Loats Associates, Westminster, MD).
6000
,000. Slide-mounted tissue sectrons (8 pm) of bovine caudate (gray matter) and bovine corpus callosum (whrte matter) were soaked for 10 min in increasing concentratrons
(1 O3 to 1 O6 cpm/lOO ~1 of water) of iodine-l 25labeled histamine at room temperature and dried rapidly under a stream of cold, dry air. The iodine-125labeled gray and white matter standards were apposed to 3H-Ultrofilm along with the CRF-labeled brain sections. After exposure, the tissue sections were scraped from the slides, and the radioactivity and protein concentration
In the gray and white matter standards were measured directly. The relationshrp between relative optical density in Ultrofilm and the concentration of Iodine-1 25 in the gray and white matter standards is shown in Figure 1 . We utilized a power functron to describe the relationship between optical density and radioactivity since the Loats image analysis system indicated a best fit for the power function as opposed to a linear or log function. The regression line had a correlation coefficient of r 2 0.99 (p < 0.001). No drfference was found In the autoradiographrc efficrency In gray and white matter labeled with iodine-125.
By generating such a standard curve concomitantly with the Nle " '251-Ty$2-oCRF autoradiograms, the film optical density readings of the samples were related to the molar concentration of radioactivity.
Results
RP-HPLC analysis of iodine-l 25.labeled Nle", Ty?'-oCRF. The RP-HPLC profile of iodine-l 25labeled and unlabeled Nle", Tyr?'-oCRF is shown in Figure 2 . Unlabeled Nle"', Ty?-oCRF eluted at 57.5 min and the iodine-125.labeled peptide eluted at 60 min. To determine whether the incubation conditions used in labeling CRF receptors on slide-mounted tissue sections resulted in any appreciable degradation of the ligand, we ran analytical profiles of aliquots of the medium before and 120 min after incubation with tissue. As seen in Figure 2 , 120 min after incubation, approximately 92% of Nle", "51-Ty?2-oCl?F remained undegraded.
The major degradation product (6.5% of total radioactivity) eluted at 45 to 48 min. In addition, minor peaks representing 3% (before incubation) and 4.5% (after incubation) of the total radioactivity eluted in the same position as iodine-125. These data demonstrate the stability of the incubation conditions for labeling CRF receptors in slidemounted tissue sections.
Biochemical characterization of CRF receptors in slide-mounted tissue sections. We carried out a series of kinetic and pharmacologic studies to define the incubation parameters and assess the properties of CRF receptors in slide-mounted brain sections. First, the rate of dissociation of Nle", lz5 I-Ty?oCRF binding was determined as a function of temperature (Fig. 3) . Slide-mounted sections of rat brain through the diencephalon were first incubated with 0.2 nM Nle*', '251-Ty?2-oCRF for 60 mm at 22°C and then washed for various times in Dulbecco's phosphate-buffered saline containing 1% BSA at either 4'C or at 22°C. Nonspecific binding was determined in the presence of 1 PM oCRF. The dissociation rates (K-J at 4°C and at 22°C were 0.046 and 0.066 min-', respectively.
Next, we examined the time course of association of Nle", '251-TyP'-oCRF with receptors at 22°C in slide-mounted sections of rat forebrain (Fig. 4) . Slide-mounted tissue sections were incubated with 0.2 nM Nle*', '25 I-Ty$*-oCRF for various times at 22°C rinsed for two 5min periods at 4°C and assayed for radioactivity. The specific binding increased with time during the first 60 min of incubation, after which there was no further significant increase. Based on these ing the histology of the olfactory bulb sectioned in the horizontal plane. 6, Darkfield photomicrograph showing the autoradiographic grain distribution on emulsion-coated coverslips over the same area shown in A. In darkfield illumination the autoradiographic silver grains appear as white spots and the tissue is not visible. In B, note the high concentration of grains in the external plexiform layer and glomerular layer with a somewhat lower concentration in the internal plexiform layer (arrowheads in A). Bar = 200 pm. AOi3, accessory olfactory bulb; E/OK ependymal olfactory ventricle: EH'external plexiform layer; GI, glomerular layer; PI, internal plexiform layer; Mi, mitral cell layer; ON, olfactory nerve layer. The anatomy of the CRF binding sites was confirmed in sections where autoradiograms were generated by apposition of emulsion-coated coverslips that were permanently affixed to the slides. A concentration of 0.2 nM Nle*' '251-Ty~-oCRF was used to label these sections. Nonspecific binding, determined in the presence of 1 /IM unlabeled Nle2', '251-Ty?3'-oCRF was uniform and comparable to that shown in Figure 58 . See the text for details. Bar = 2 mm. observatrons, all subsequent autoradrographic studies utilized a 60. to 90-min Incubation at 22°C followed by two 5min washes at 4°C.
In a previous study (De Souza et al., 1984b) , we defined the characteristrcs of Nle*', lZ5 I-Ty$"-oCRF binding in rat brain under conditions defined above. We incubated serial slide-mounted tissue sections with increasing concentrations of CRF-related and unrelated peptides. The binding of Nle ", '251-TyP-oCRF in rat striatum was saturable and, on Scatchard analysis, revealed a high affinity component with an apparent Kd of 6.2 + 0.8 nM and a low affinity binding site with a Kd of approximately 100 nM. In competition studies, 1 PM rat (human) CRF and ovine CRF inhibited 105% and 81%, respectively, of the specific Nle ", '251-Ty~2-oCRF binding in rat striatum. Two fragments of oCRF, CRF( l-39) and CRF ( I-22) Vol. 5, No. 12, Dec. 1985 figure 9. Binding of Nle 2' '251-Ty$2-oCRF in the rat medial hypothalamus.
A, Brightfield photomicrograph of a toluidine blue-stained tissue section showing , a high power view of the median eminence of the hypothalamus (ME) at the base of the third ventricle (V). B, Darkfield photomicrograph showing the autoradiographic grain distribution on Kodak NTB3 emulsion-coated coverslips over the same area shown in A. In B note that the concentration of grains in the external layer of the median eminence (arrows) is higher than in the remainder of the hypothalamus.
matter tracts such as corpus callosum, fornix, and optic chiasm. In describing the distribution of Nle", '251-Ty?2-oCRF-binding sites which follows, qualitative expressions of receptor density will correspond to the relative binding values in Table Ill : very low levels, specific binding of 0 to 20 fmol/mg of protein; low levels, 20 to 40 fmol/mg of protein; moderate levels, 40 to 80 fmol/mg of protein; high levels, 80 to 100 fmol/mg of protein; and very high levels, >I00 fmol/mg of protein. Nonspecific binding was consistently uniform in all brain areas (Fig. 5B) and. was subtracted from the total binding to calculate specific binding. CRF receptors were found throughout the neocortex. Within the neocortex, high grain densities were present in laminae 1 and 4 with moderate levels observed in lamina 2, 3, 5 and 6 (Fig. 6, Table II ). Although this laminar distribution of Nle"', '251-Ty$'-oCRF-binding sites was maintained throughout the neocortex, on the average, more binding sites were found in somatosensory (see Fig. 8 , B to F), striate (see Fig. 8 /-f), and entorhinal (see Fig. 8G ) cortex than in motor (see Fig. 8 , B to f) and cingulate (see Fig. 8 , B to F) cortex.
A change in the pattern of CRF binding was seen at the transition of the neocortex and the pyriform cortex near the rhinal fissure (see Fig. 8 , B and C). In the pynform cortex, a high density of binding sites was present only in lamina I, with much lower levels found in and the adjacent glomerular layer. Low to negligible concentrations of receptors were found in the remainder of the bulb including the nerve fiber, internal plexiform, mitral cell body, and internal granule layers of the olfactory bulb.
In the corpus striatum, moderate levels of CRF receptors were observed in the caudate-putamen (Fig. 8, f3 to F). The adjacent globus pallidus (Fig. 80) had a low density of CRF-binding sites. Moderate arain densities were observed over the claustrum (Fig. 8 , A and C).-Moderately high levels of specific binding were associated with the nucleus accumbens (Fig. 8A) , with slightly higher grain densities observed over the medial than the lateral-pa& of this nucleus (Fig.  88 ). Low to moderate grain densities were observed over both the. vertical and horizontal limbs of the nucleus and tract of the diagonal band (Fig. 8C) . Low levels of CRF binding were present in the areas of medial and lateral septal nuclei (Fig. 8C ) and triangular septal nucleus (Fig. 80) , and slightly higher levels were present in the bed nucleus of the stria terminalis. In the amygdala, low concentrations of receptors were observed in the medial and central nuclei, whereas a moderate concentration of CRF receptors was present in the basolateral nucleus (Fig. 8, E and F) .
There was a fairly uniform, low to moderate level of CRF-binding *a. , the remaining laminae. A high grain density was found in the external sites throughout the thalamus with a slightly higner concenrrarlon OT plexiform layer of the olfactory tubercle, whereas low density binding grains observed in the lateral compared to the medial thalamus ( Fig.  was observed in the pyramidal and polymorphic layers of the 8, E and F). In the dorsal thalamic complex, a higher concentration tubercle as well as in the islands of Calleja (see Fig. 8C ). No specific CRF binding was present in the lateral olfactory tract (see Fig. 8 , A
of receptors was associated with the anterodorsal nucleus (Fig. 8E) .
to C). In the olfactory bulb (Fig. 7 , Table I Vol. 5, No. 12, Dec. 1985 Overall, the hippocampus contained a low concentration of CRF receptors (Fig. 8 , E to G). Within the hippocampus, the highest concentrations of binding sites were present in the subiculum (Fig.  8G) , the molecular layer of the dentate gyrus, and the CA1 region (Fig. 8F) . Lower concentrations of binding sites were found in the remaining areas of this brain region. In the midbrain a moderate level of CRF receptors was seen in the inferior colliculus (Fig. 8, H and I ). Within the inferior colliculus, the ventrolateral aspects had higher grain densities than did the dorsomedial portion. Fairly dense labeling of CRF receptors was found in the trochlear nuclei and in the interpedunuclar nucleus (Fig.  8G ). Low levels of CRF receptors were present in the periaqueductal gray, dorsal raphe nucleus (Fig. 8G) , and superior colliculus, and very low concentrations were seen in the substantia nigra. In the pons, the cranial nerve nuclei including the facial (Fig. 8 , J and K), trigeminal (Fig. 8, I to K), cochlear (Fig. 8K) , and vestibular nuclei (Fig. 8K) (Fig. 8L) , lateral reticular, paragigantocellular reticular, parabrachial and dorsal (Fig. 8J) , and ventral tegmental nuclei. The pontine nuclei (Fig. 8, G and H) themselves and the raphe pontis nucleus (Fig. 8, I and J) contained moderate to low numbers of grains, whereas the pontine reticular nuclei (Fig. 8H ) had a very low density of CRF receptors.
Very low levels of receptors were found in the locus ceruleus (Fig. 8J ). In the medulla, the highest receptor densities were found in the cuneate and gracilis nuclei (Fig. 8L) . High grain densities were also found in the inferior olive (Fig. 8L) . et al., 1983; De Souza et al., 1984a; Holmes et al., 1984) , human (De Souza et al., 1985) , and bovine (De Souza and Kuhar, 1985) pituitary glands and in the rat Intermediate pituitary gland (De Souza et al., 1984a) . These data substantiate earlier suggestions (Peterfreund and Vale, 1983; Valentino et al., 1983; D. R. Britton et al., 1984) that some structural requrrements for CRF activity are shared by brain and pituitary receptors.
The densities of CRF receptors in the rat CNS are generally consistent with the relative distribution of CRF-immunoreactive (CRF-IR) terminals (Bloom et al., 1982; Bugnon et al., 1982; Olschowka et al., 1982; Cummings et al., 1983; Joseph and Knigge, 1983; Lerenth et al., 1983; Merchenthaler et al., 1983; Paul1 and Gibbs, 1983; Swanson et al., 1983 1982; Cummings et al., 1983; Merchenthaler et al., 1983; Swanson et al., 1983) whereas the highest concentration of CRF receptors is present in the basolateral nucleus.
The cerebellum provides a very striking example of a disparity between the anatomical distribution of Nle", '251-Tyra"-oCRF-binding sites and CRF-IR fibers.
In the rat cerebellum, moderate (Merchenthaler et al., 1983; Cummings et al., 1983) , low (Olschowka et al., 1982) , and undetectable (Swanson et al., 1983) densities of CRF-IR fibers have been reported. In contrast, the concentration of cerebellar binding sites is one of the highest in the rat CNS. In the spinal cord, laminae I and II of the dorsal horn contained the highest numbers of CRF-IR fibers (Olschowka et al., 1982; Schipper et al., 1983) Vol. 5, No. 12, Dec. 1985 problem" has been the topic of a recent report (Kuhar, 1985) . There should not be a match between receptor and neurotransmitter at the light microscopic level in whole sections. Neurotransmitter is contained throughout a neuron, whereas the receptor is contained in the postsynaptic neuron which has a different spatial distribution. Perhaps only when both neurons are interneurons and contained within the same region would a match be expected. Technical limitations in both autoradiographic and immunocytochemical experiments may prevent the complete and appropriate identification of receptor and neurotransmitter molecules, respectively. Subtypes of the CRF receptor may exist which only bind under an appropriate set of conditions such as ligand concentration, salts, and guanyl nucleotides. Also, agonist ligands similar to the radioiodinated CRF analogue used in the present study primarily label high affinity states of the receptor which may not be found in constant proportions in all regions of the CNS. lmmunohistochemistry, in contrast, is dependent on the specificity of the antisera used. Most of the reports (see above) on the immunohistochemical distribution of CRF in rat brain have utilized primary antibodies directed against ovine CRF. Different distributions of CRF immunoreactivity in the rat CNS were recently reported using a variety of antibodies directed against rat and ovine CRF (Skofitsch and Jacobowitz, 1984) . Future studies utilizing more specific antisera in combination with better radioligands may minimize the discrepancies between the distribution of CRF receptors and of CRF immunoreactivity.
Low to moderate concentrations of CRF-binding sites are present in several regions of the rat CNS known to contain primary groups of CRF-IR cell bodies such as the paraventricular nucleus of the hypothalamus, the central nucleus of the amygdala, the bed nucleus of the stria terminalis, and the nucleus of the solitary tract. These CRF-binding sites may represent presynaptic autoreceptors or receptors for internuclear communication which may play important roles in regulating peptide release originating from these perikarya.
CRF-binding sites are present in high concentrations in the median eminence. We are presently investigating the pharmacological characteristics of these CRF-binding sites in the median eminence. Several alternatives exist to explain the nature of the CRF binding in the median eminence. The binding sites may be presynaptic autoreceptors regulating the release of CRF into the portal vasculature. The CRF-binding sites in the median eminence may also represent interactions of CRF with proteins associated with ependymal tanycytes which may function to transport CRF from the cerebrospinal fluid to the hypophysial portal vasculature (Zimmerman et al., 1973) . Another possibility is that the CRF binding in the median eminence may be to CRF receptors on blood vessels similar to those described for vasopressin (Schiffrin and Genest, 1983) . Although the precise role of these CRF-binding sites is unclear, similar distributions of receptors in the median eminence have been reported for other hypothalamic hypophysiotropic neurotransmitters such as vasopressin (Brinton et al., 1984) and dopamine (Cronin and Weiner, 1979) .
There is relatively good correspondence within the rat CNS between areas containing CRF receptors and anatomic loci which are electrophysiologically responsive to CRF. lontophoretic application of CRF excited in the cortex and hypothalamus and inhibited in the thalamus and lateral septal area spontaneously occurring action potentials (Eberly et al., 1983) . CRF has also been demonstrated to produce excitation of hippocampal pyramidal cells in an in vitro hippocampal slice preparation (Aldenhoff et al., 1983) . Direct microapplication of CRF to parabrachial neurons increased the discharge rate of these cells (Valentino et al., 1983) . Intracerebroventricular administration of low doses of CRF in rats produced changes in electroencephalographic activity suggestive of increased arousal, whereas high doses of CRF elicited seizures that appeared electroencephalographically to originate in the amygdala (Ehlers et al., 1983) . In contrast to the good correlation between the presence of CRF receptors and electrophysiologically responsive cells described above, CRF has been shown to directly activate noradrenergic neurons of the locus ceruleus (Valentino et al., 1983 ) an area with a low concentration of CRF-binding sites, A role has been proposed for CRF in the control of food intake (Morley and Levine, 1982; D. R. Britton et al., 1982 D. R. Britton et al., , 1984 Gosnell et al., 1983; Levine et al., 1983) . The medial and lateral hypothalamus represent important brain areas that are involved in regulating food intake (see Stevenson 1969; Grossman, 1975) . The hypothalamus may represent a primary site of action for integrating some endocrine and behavioral effects of CRF. Microinfusion of CRF into the arcuateventromedial area of the hypothalamus suppresses sexual behavior (Sirinathsinghji et al., 1983) . In addition, intracerebroventricular injections of CRF have been shown to have antipyretic effects (Bernardini et al., 1984) to inhibit the release of growth hormone (Ono et al., 1984; Rivier and Vale, 1984b) , luteinizing hormone (One et al., 1984; Rivier and Vale, 1984a), vasopressin, and oxytocin (Plotsky et al., 1984) and to have deleterious actions on reproductive functions (Rivier and Vale, 1984a) . CRF can stimulate the secretion of somatostatin by cultured rat hypothalamic and cerebral cortical cells (Peterfreund and Vale, 1983) .
The distribution of CRF receptors in the rat olfactory system is striking. Within the olfactory bulb, the CRF-binding sites are discretely localized in the glomerular layer where the primary olfactory afferent axons terminate (Sheppard, 1979) and in the adjacent external plexiform layer and in the mitral cell body layer where the olfactory output neurons originate (Sheppard, 1979) . There is evidence in the literature suggesting that sexual, reproductive, social, and feeding behaviors of most mammalian species are mediated by olfactory substances and pheromonal agents acting through the olfactory system (see Whitten and Bronson, 1970) . CRF influences both feeding behavior and sexual activity (see above). Although the hypothalamus is the primary anatomical locus regulating sexual activity and feeding behavior, hypothalamic neuronal activity can be modulated by olfactory impulses relayed through the circuit involving the olfactory bulb, pyriform cortex, amygdala, and subiculum (Lohman, 1963; Powell et al., 1965; Cain and Bindra, 1972; Dreifuss, 1972; Kretteck and Price, 1978a, b) ; moderate to high densities of CRF receptors are present throughout the circuits.
CRF injected intracerebroventrically produced dose-dependent locomotor activation (Sutton et al., 1982; D. R. Britton et al., 1982 D. R. Britton et al., , 1984 Koob et al., 1984) . High concentrations of CRF receptors were detected in several brain areas subserving motor function. These structures include the caudate-putamen, the cerebellum, and the facial and hypoglossal motor cranial nerve nuclei. Our localization of CRF-binding sites in the ventral horn of the spinal cord may demonstrate another potential site for CRF to centrally affect motor activity.
CRF acts within the CNS to elicit changes in the activity of the autonomic nervous system similar to those changes produced by many forms of stress. The autonomic effects of CRF are evident in a variety of species including rats (Brown et al., 1982a (Brown et al., , b, c, 1984 Fisher et al., 1982 Fisher et al., , 1983 Tache et al., 1983 Tache et al., , 1984 Fisher and Brown, 1984; Hamel and Tache, 1984) dogs, (Brown et al., 1982~; Tache et al., 1984) sheep (Scoggins et al., 1984) and monkeys (Kalin et al., 1983; lnsel et al., 1984) and include increased plasma concentrations of epinephrine, norepinephrine, glucose, glucagon, cardiovascular parameters such as heart rate and mean arterial pressure, and decreased gastric acid secretion. The present study provides an anatomical basis for some of the observed effects of CRF on autonomic function. CRF may produce some of its effects via receptors in the parabrachial nucleus, medullary reticular formation, nucleus of the solitary tract, or other brainstem areas known to participate in autonomic regulation. CRF-binding sites are also present in several forebrain regions that exert a powerful influence on autonomic outflow. These regions include the hypothalamus, especially the paraventricular nucleus, bed nucleus of the stria terminalis, amygdala, septum and hippocampus, and cingulate cortex. The autonomic effects of CRF administration may also be mediated by receptors in the spinal cord as suggested by effects of intrathecal injections of CRF at the lumbar level to inhibit gastric acid secretion (Hamel and Tache, 1984) .
The immunohistochemical, electrophysiological, behavioral, phar-
The Journal of Neuroscience Corticotropin-releasing Factor Receptors in Rat CNS 3201 macological, and receptor studies provide compelling evidence that endogenous CRF may function as a neurotransmitter in the CNS. The data discussed above suggest a key role for this neuropeptide in the endocrine, autonomic, and behavioral responses to stress that are characteristic of Selye's "general adaptation syndrome." There are some preliminary studies that support a role for endogenous CRF in stress. Footshock stress increased the CSF levels of CRF immunoreactivity in rats (K. T. Britton et al., 1984) . Central administration of a CRF receptor antagonist in rats produced dosedependent inhibition of the plasma epinephrine response to ether stress-or insulin-induced hypoglycemia (Brown et al., 1984) . In summary, we have used the radioiodinated ovine CRF analogue, Nle", '*51-Ty~'-oCRF to map CRF-binding sites in the rat CNS using in vitro labeling autoradiographic techniques. The areas of distribution of CRF-binding sites are correlated well with the immunohistochemical distribution of CRF pathways and pharmacological sites of action of CRF. These data strongly support a physiological role for endogenous CRF in regulating and integrating CNS activity and suggest the importance of this neuropeptide in regulating endocrine and visceral functions and behavior, especially in response to stressful stimuli. The exact mechanisms by which CRF can modulate these complex functions remain unknown. Studies to characterize CRF receptors and CRF-containing pathways in the brain provide a means for better understanding the various functions of this neuropeptide in different areas of the CNS. 
